Total Payments
$95,691
2024 Payments
$42,944
Companies
20
Transactions
258
Medicare Patients
1,155
Medicare Billing
$958,799
Payment Breakdown by Category
Other$70,520 (73.7%)
Consulting$10,125 (10.6%)
Food & Beverage$8,204 (8.6%)
Travel$6,743 (7.0%)
Education$98.34 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $70,520 | 32 | 73.7% |
| Consulting Fee | $10,125 | 6 | 10.6% |
| Food and Beverage | $8,204 | 186 | 8.6% |
| Travel and Lodging | $6,743 | 33 | 7.0% |
| Education | $98.34 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $81,183 | 113 | $0 (2024) |
| Medtronic USA, Inc. | $6,769 | 13 | $0 (2020) |
| Entellus Medical, Inc. | $1,965 | 18 | $0 (2018) |
| Stryker Corporation | $1,483 | 22 | $0 (2024) |
| AERIN MEDICAL INC. | $1,451 | 19 | $0 (2023) |
| ABBVIE INC. | $742.27 | 25 | $0 (2024) |
| Medtronic, Inc. | $326.10 | 4 | $0 (2023) |
| Intersect ENT, Inc. | $287.80 | 8 | $0 (2021) |
| GENZYME CORPORATION | $283.32 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $225.77 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42,944 | 64 | Optinose US, Inc. ($41,986) |
| 2023 | $12,932 | 59 | Optinose US, Inc. ($10,688) |
| 2022 | $29,379 | 63 | OptiNose US, Inc. ($28,328) |
| 2021 | $533.66 | 18 | Optinose US, Inc. ($180.39) |
| 2020 | $773.94 | 3 | Medtronic USA, Inc. ($540.00) |
| 2019 | $6,636 | 22 | Medtronic USA, Inc. ($6,129) |
| 2018 | $424.92 | 8 | Stryker Corporation ($177.60) |
| 2017 | $2,069 | 21 | Entellus Medical, Inc. ($1,851) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Optinose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/09/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $85.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $91.68 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Immunology | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.49 | General |
| Category: Immunology | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.49 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/11/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $69.68 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $98.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/04/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/04/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/04/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/27/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/27/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/27/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $261.25 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/27/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $137.81 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/27/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $8.75 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $44.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: PAIN | ||||||
| 08/07/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 361 | 1,039 | $1.1M | $382,771 |
| 2022 | 7 | 305 | 1,022 | $829,796 | $309,363 |
| 2021 | 6 | 230 | 679 | $390,909 | $182,161 |
| 2020 | 6 | 259 | 632 | $236,017 | $84,504 |
Total Patients
1,155
Total Services
3,372
Medicare Billing
$958,799
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31298 | Dilation of sphenoid and frontal nasal sinus using an endoscope | Office | 2023 | 44 | 49 | $494,359 | $168,597 | 34.1% |
| 31295 | Dilation of nasal sinus using an endoscope | Office | 2023 | 44 | 49 | $260,849 | $79,098 | 30.3% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 57 | 212 | $152,837 | $59,518 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 380 | $72,101 | $34,611 | 48.0% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 70 | 246 | $69,645 | $33,402 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 83 | $11,081 | $5,264 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,935 | $2,280 | 46.2% |
| 31298 | Dilation of sphenoid and frontal nasal sinus using an endoscope | Office | 2022 | 27 | 33 | $332,936 | $114,711 | 34.5% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 51 | 247 | $177,935 | $68,823 | 38.7% |
| 31295 | Dilation of nasal sinus using an endoscope | Office | 2022 | 26 | 32 | $170,350 | $54,087 | 31.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 62 | 223 | $63,134 | $30,783 | 48.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 331 | $62,804 | $29,927 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 140 | $18,690 | $9,210 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,948 | $1,822 | 46.2% |
| 31298 | Dilation of sphenoid and frontal sinus in the nose using an endoscope | Office | 2021 | 13 | 13 | $95,845 | $53,313 | 55.6% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2021 | 38 | 175 | $141,488 | $52,574 | 37.2% |
| 31295 | Dilation of maxillary sinus in the nose using an endoscope | Office | 2021 | 13 | 13 | $50,573 | $25,138 | 49.7% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 63 | 167 | $50,099 | $23,921 | 47.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 220 | $40,955 | $21,095 | 51.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 91 | $11,950 | $6,120 | 51.2% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2020 | 43 | 135 | $136,170 | $39,166 | 28.8% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2020 | 64 | 155 | $46,500 | $22,353 | 48.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 168 | $26,880 | $12,429 | 46.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 138 | $16,560 | $7,722 | 46.6% |
| 70486 | Ct scan of face | Office | 2020 | 18 | 25 | $8,037 | $1,914 | 23.8% |
About Dr. Subinoy Das, MD
Dr. Subinoy Das, MD is a Otolaryngology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063461663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Subinoy Das, MD has received a total of $95,691 in payments from pharmaceutical and medical device companies, with $42,944 received in 2024. These payments were reported across 258 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($70,520).
As a Medicare-enrolled provider, Das has provided services to 1,155 Medicare beneficiaries, totaling 3,372 services with total Medicare billing of $958,799. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Columbus, OH
- Active Since 05/09/2006
- Last Updated 07/02/2021
- Taxonomy Code 207Y00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063461663
Products in Payments
- Xhance (Drug) $81,183
- NovaShield (Device) $6,050
- XprESS Multi-Sinus Dilation System (Device) $1,851
- VIVAER STYLUS (Device) $1,262
- QULIPTA (Drug) $499.34
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $413.98
- DUPIXENT (Biological) $407.44
- PROPEL (Device) $378.78
- XPRESS ENT DILATION SYSTEM (Device) $276.16
- SCOPIS ENT (Device) $262.84
- TEPEZZA (Drug) $222.00
- XPRESS LOPROFILE (Device) $182.39
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM (Device) $164.92
- LATERA (Device) $149.68
- UBRELVY (Drug) $128.42
- TruDi (Device) $121.20
- NUCALA (Biological) $113.08
- Latera (Device) $106.61
- Sophono (Device) $99.53
- ZAVZPRET (Drug) $91.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Columbus
Eugene Chio, Md, MD
Otolaryngology — Payments: $37,172
Otolaryngology $37,172
Dr. Laura Matrka, M.d, M.D
Otolaryngology — Payments: $13,645
Otolaryngology $13,645
Nicholas Hollenkamp, Md, MD
Otolaryngology — Payments: $13,508
Otolaryngology $13,508
Dr. Ricardo Carrau, Md, MD
Otolaryngology — Payments: $11,192
Otolaryngology $11,192
Desi Schoo, M.d, M.D
Otolaryngology — Payments: $10,981
Otolaryngology $10,981
Stephen Nogan, M.d, M.D
Otolaryngology — Payments: $10,417
Otolaryngology $10,417